Oxford Biomedica Regulatory News (OXB)

1 Feb 2005 12:07

Man Financial Limited01 February 2005 Date Of Disclosure: 01/02/05 Fax to 020 7256 9386 (Take Over Panel) and 020 7588 6057 (RNS) FORM 8.1/8.3 Lodge with a RIS or Newstrack and the Takeover Panel. Use separate form for each class of securities in which dealings have been made. DISCLOSURE UNDER RULES 8.1(a), 8.1(b)(i) AND 8.3 OF THE CITY CODEON TAKEOVERS AND MERGERS Date of dealing 31/01/05 (1) Name of Company Dealing in OXFORD BIOMEDICA PLC Class of securities ORDINARY SHARES (2) Amount Bought Amount Sold Price (GBP) 250000 0.2550 In addition, MAN FIN LTD have entered into CFD arrangements with it's client's which are detailed below. (3) Resultant total of the same class owned or controlled and 20,650,800 5.56% percentage of class (4) Party making disclosure MAN FINANCIAL LIMITED (5) Name of purchaser/vendor (Note1) MAN FINANCIAL LIMITED (6) Reason for disclosure (Note 2) (a) Associate of (i) offeror (Note 3) - NO (b) (i) offeree Company - NO Specify which category or categories of associate (1-8 overleaf) If category (8), explain Rule 8.3 (i.e. disclosure because of ownership or control of 1% or more of the class of relevant securities dealt in) - YES Signed, for and on behalf of the party named in (4) above Stewart Horner Telephone and extension number 020-7144-4201 Note 1. Specify owner, not nominee or vehicle company. If relevant, also identify controller of owner, e.g. where an owner normally acts on instructions of a controller. Note 2. Disclosure might be made for more than one reason; if so, state all reasons. Note 3. Specify which offeror if there is more than one. Note 4. When an arrangement exists with any offeror, with the offeree company or with an associate of any offeror or of the offeree company in relation to relevant securities, details of such arrangement must be disclosed, as required by Note 6 on Rule 8. Note 5. It may be necessary, particularly when disclosing derivative transactions, to append a sheet to this disclosure form so that all relevant information can be given. Note 6. In the case of an average price bargain, each underlying trade should be disclosed For full details of disclosure requirements, see Rule 8 of the Code. If in doubt, contact the Panel on Takeovers and Mergers, Monitoring Section,Tel. No: 020 7638 0129. E-mail:monitoring@disclosure.org.uk NOTES REGARDING DISCLOSURE MAN FIN Ltd is the beneficial owner of 20,650,800 Ordinary Shares in the above company which are held to hedge CFD & Spread Betting positions (see below) established between MAN Financial Ltd and its clients.A Contract for Difference or CFD is an agreement between two parties to exchange, at the close of the contract, the difference between the opening price and the closing price, multiplied by the number of reference shares specified within the contract. The 'reference shares' are the underlying shares specified in the CFD. The economic performance of the CFD is determined by the performance of the underlying reference shares. Although CFDs replicate the price movement of the underlying reference shares,they convey no right or requirement to acquire or deliver the physical shares.The contract value of a CFD is defined as the number of reference shares specified in the contract, multiplied by the price of the underlying reference share. If a client of Man takes a long position, the customer will make a profit if the contract value increases. Conversely, if a customer of Man Financial Ltd takes a short position, the customer will benefit if the contract value falls.The CFD contracts detailed below are open-ended and without predetermined expiry/close valueA Spread Bet is a product where the client to whom the product is sold can realise a gain or a loss depending on whether the price of the underlying security increases above or falls below the reference price. The client's Spread bet position is described as his "stake". A "stake" is expressed in pounds (sterling) per "point" and a "point" is the price in pence of the underlying shares. A client with a "stake" of £100 per point will make a gain of £100 for every penny increase in the underlying shares and he/she has an exposure equivalent to 10,000 shares. DEFINITION OF ASSOCIATE It is not practicable to define associate in terms which would cover all thedifferent relationships which may exist in an offer. The term associate isintended to cover all persons (whether or not acting in concert) who directly orindirectly own or deal in the shares of an offeror or the offeree company inan offer and who have (in addition to their normal interests as shareholders)an interest or potential interest, whether commercial, financial or personal,in the outcome of the offer Without prejudice to the generality of theforegoing, the term associate will normally include the following:- (1) an offeror's or the offeree company's parent, subsidiaries and fellow subsidiaries, and their associated companies, and companies of which such companies are associated companies (for this purpose ownership or control of 20% or more of the equity share capital of a company is regarded as the test of associated company status); (2) banks and financial and other professional advisers (including stockbrokers)* to an offeror, the offeree company or any company covered in (1), including persons controlling#, controlled by or under the same control as such banks, financial and other professional advisers; (3) the directors (together with their close relatives & related trusts) of an offeror, the offeree company or any company covered in (1); (4) the pension funds of an offeror, the offeree company or any company covered in (1); (5) any investment company, unit trust or other person whose investments an associate manages on a discretionary basis, in respect of the relevant investment accounts; (6) a person who owns or controls 5% or more of any class of relevant securities (as defined in paragraphs (a) to (d) in Note 2 on Rule 8) issued by an offeror or an offeree company, including a person who as a result of any transaction owns or controls 5% or more. When two or more persons act pursuant to an agreement or understanding (formal or informal) to acquire or control such securities, they will be deemed to be a single person for the purpose of this paragraph. Such securities managed on a discretionary basis by an investment management group will, unless otherwise agreed by the Panel, also be deemed to be those of a single person (see Note 8 on Rule 8); and (7) a company having a material trading arrangement with an offeror or the offeree company. Paragraphs (1)-(7) are typical cases. Paragraph (8) below is a category to cover associate status not within (1) -(7). (8) Other. CFD OPEN INTEREST ----------------- No. of Ref PRODUCT NAME EXECUTED MAN FIN LTD Shares PRICE (GBP) ------------ -------- ----------- ---------- ----------- OXFORD BIOMEDICA PLC LONG CFD 31/01/05 SALE 250,000 0.2550 OXFORD BIOMEDICA PLC LONG CFD 28/01/05 SALE 400,000 0.2500 OXFORD BIOMEDICA PLC LONG CFD 28/01/05 SALE 250,000 0.2575 OXFORD BIOMEDICA PLC LONG CFD 27/01/05 SALE 100,000 0.2600 OXFORD BIOMEDICA PLC LONG CFD 27/01/05 SALE 50,000 0.2450 OXFORD BIOMEDICA PLC LONG CFD 26/01/05 SALE 250,000 0.2350 OXFORD BIOMEDICA PLC LONG CFD 25/01/05 SALE 500,000 0.2250 OXFORD BIOMEDICA PLC LONG CFD 25/01/05 SALE 250,000 0.2300 OXFORD BIOMEDICA PLC LONG CFD 25/01/05 SALE 1,000,000 0.2350 OXFORD BIOMEDICA PLC LONG CFD 24/01/05 SALE 100,000 0.2250 OXFORD BIOMEDICA PLC LONG CFD 20/01/05 SALE 100,000 0.1925 OXFORD BIOMEDICA PLC LONG CFD 19/01/05 SALE 390,000 0.2275 OXFORD BIOMEDICA PLC LONG CFD 19/01/05 SALE 250,000 0.2345 OXFORD BIOMEDICA PLC LONG CFD 19/01/05 SALE 25,000 0.2250 OXFORD BIOMEDICA PLC LONG CFD 18/01/05 SALE 325,000 0.1896 OXFORD BIOMEDICA PLC LONG CFD 26/11/04 SALE 50,000 0.1700 OXFORD BIOMEDICA PLC LONG CFD 18/11/04 SALE 100,000 0.1788 OXFORD BIOMEDICA PLC LONG CFD 16/11/04 SALE 100,000 0.1850 OXFORD BIOMEDICA PLC LONG CFD 05/11/04 SALE 100,000 0.2088 OXFORD BIOMEDICA PLC LONG CFD 29/10/04 SALE 3,250,000 0.1925 OXFORD BIOMEDICA PLC LONG CFD 29/10/04 SALE 100,000 0.1888 OXFORD BIOMEDICA PLC LONG CFD 08/10/04 SALE 100,000 0.2025 OXFORD BIOMEDICA PLC LONG CFD 07/10/04 SALE 200,000 0.2000 OXFORD BIOMEDICA PLC LONG CFD 06/10/04 SALE 25,000 0.1850 OXFORD BIOMEDICA PLC LONG CFD 05/10/04 SALE 500,000 0.1950 OXFORD BIOMEDICA PLC LONG CFD 04/10/04 SALE 30,000 0.1800 OXFORD BIOMEDICA PLC LONG CFD 04/10/04 SALE 250,000 0.1875 OXFORD BIOMEDICA PLC LONG CFD 01/10/04 SALE 500,000 0.1675 OXFORD BIOMEDICA PLC LONG CFD 01/10/04 SALE 250,000 0.1700 OXFORD BIOMEDICA PLC LONG CFD 30/09/04 SALE 200,000 0.1650 OXFORD BIOMEDICA PLC LONG CFD 29/09/04 SALE 42,200 0.1600 OXFORD BIOMEDICA PLC LONG CFD 23/09/04 SALE 50,000 0.1725 OXFORD BIOMEDICA PLC LONG CFD 17/09/04 SALE 80,000 0.1750 OXFORD BIOMEDICA PLC LONG CFD 16/09/04 SALE 150,000 0.1650 OXFORD BIOMEDICA PLC LONG CFD 31/08/04 SALE 50,000 0.1750 OXFORD BIOMEDICA PLC LONG CFD 31/08/04 SALE 25,000 0.1750 OXFORD BIOMEDICA PLC LONG CFD 05/07/04 SALE 50,000 0.1965 OXFORD BIOMEDICA PLC LONG CFD 24/06/04 SALE 150,000 0.1950 OXFORD BIOMEDICA PLC LONG CFD 22/06/04 SALE 100,000 0.1900 OXFORD BIOMEDICA PLC LONG CFD 21/06/04 SALE 100,000 0.1900 OXFORD BIOMEDICA PLC LONG CFD 10/06/04 SALE 50,000 0.2000 OXFORD BIOMEDICA PLC LONG CFD 08/06/04 SALE 500,000 0.1995 OXFORD BIOMEDICA PLC LONG CFD 07/06/04 SALE 100,000 0.1925 OXFORD BIOMEDICA PLC LONG CFD 04/06/04 SALE 500,000 0.1925 OXFORD BIOMEDICA PLC LONG CFD 04/06/04 SALE 100,000 0.1975 OXFORD BIOMEDICA PLC LONG CFD 04/06/04 SALE 100,000 0.1925 OXFORD BIOMEDICA PLC LONG CFD 04/06/04 SALE 100,000 0.1875 OXFORD BIOMEDICA PLC LONG CFD 02/06/04 SALE 500,000 0.1913 OXFORD BIOMEDICA PLC LONG CFD 02/06/04 SALE 60,000 0.1925 OXFORD BIOMEDICA PLC LONG CFD 28/05/04 SALE 375,000 0.1690 OXFORD BIOMEDICA PLC LONG CFD 13/05/04 SALE 1,925,000 0.1750 OXFORD BIOMEDICA PLC LONG CFD 23/04/04 SALE 50,000 0.2125 OXFORD BIOMEDICA PLC LONG CFD 08/04/04 SALE 100,000 0.1975 OXFORD BIOMEDICA PLC LONG CFD 30/03/04 SALE 100,000 0.2375 OXFORD BIOMEDICA PLC LONG CFD 03/03/04 SALE 150,000 0.2700 OXFORD BIOMEDICA PLC LONG CFD 01/03/04 SALE 50,000 0.2840 OXFORD BIOMEDICA PLC LONG CFD 26/02/04 SALE 50,000 0.2700 OXFORD BIOMEDICA PLC LONG CFD 10/02/04 SALE 100,000 0.2575 OXFORD BIOMEDICA PLC LONG CFD 06/02/04 SALE 350,000 0.2668 OXFORD BIOMEDICA PLC LONG CFD 05/02/04 SALE 750,000 0.2350 OXFORD BIOMEDICA PLC LONG CFD 04/02/04 SALE 158,000 0.2475 OXFORD BIOMEDICA PLC LONG CFD 27/10/03 SALE 2,505,600 0.0000 OXFORD BIOMEDICA PLC LONG CFD 08/05/03 SALE 120,000 0.0825 OXFORD BIOMEDICA PLC LONG CFD 06/05/03 SALE 1,000,000 0.0713 OXFORD BIOMEDICA PLC LONG CFD 10/03/03 SALE 40,000 0.0725 SPREAD BETTING OPEN POSITIONS - £1 = 1p Per Point SECURITY PROMPT TRADE CURRENC STAKE BUY/SEL OPEN OXFORD 15/03/05 28/01/05 GBP 250 BUY 25.25 BIOMEDICA PLC This information is provided by RNS The company news service from the London Stock Exchange